Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

A Phase I/IIa Study of Lemzoparlimab, a Monoclonal Antibody Targeting CD47, in Patients with Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS): Initial Phase I Results

Junyuan Qi, MD, Jian Li, MD, Bin Jiang, MD, Bo Jiang, MD, Hongzhong Liu, MD, Xinxin Cao, MD, Meixiang Zhang, MD, Yuan Meng, MD, Xiaoyu MA, Yingmin Jia, Jiyuan Guo, Yanni Zhang, Wei Huang, Jianxiang Wang, MD

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-134391

Published: 2020

Journal Articles

Retrospective Study Evaluating Hematological Remission Rates and Survival in Chinese Adults with Relapsed or Refractory (r/r) Philadelphia Chromosome Negative (Ph - ) B-Precursor Acute Lymphoblastic Leukemia (ALL)

Jun Ma, MD, Ting Liu, MD, Jie Jin, MD PhD, Jianda Hu, MD PhD, Qifa Liu, MD, Jianxiang Wang, MD, Zhixiang Shen, MD, Xin Du, MD PhD, Bin Jiang, MD, Xianhua Meng, PhD

Blood (2016) 128 (22): 5198.

https://doi.org/10.1182/blood.V128.22.5198.5198

Published: 2016

Journal Articles

Prevalence and Prognostic Significance of c-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia: A Comprehensive Large-Scale Study from a Single Chinese Center

Ya-Zhen Qin, Honghu Zhu, Qian Jiang, Hao Jiang, Le-Ping Zhang, Jin-Lan Li, Ling-Di Li, Yan-Rong Liu, Yue-Yun Lai, Hong-Xia Shi, Bin Jiang, MD, Xiao-Jun Huang, MDPhD

Blood (2014) 124 (21): 1000.

https://doi.org/10.1182/blood.V124.21.1000.1000

Published: 2014

Journal Articles

KIT Mutation Versus MRD, Which Is More Important To Predict Relapse Of Acute Myeloid Leukemia With t (8; 21)?

Hong-Hu Zhu, MD, Daihong Liu, Hao Jiang, Ya-Zhen Qin, MS, Lan-Ping Xu, MD, Qian Jiang, Xiao-Hui Zhang, M.D., Ph.D., Huan Chen, Jin Lu, MD, Yu Wang, Li-Ru Wang, MD, Jun-Yue Chai, MM, Kai-Yan Liu, MD, Bin Jiang, MD, Xiao-Jun Huang, MD, PhD

Blood (2013) 122 (21): 1309.

https://doi.org/10.1182/blood.V122.21.1309.1309

Published: 2013

Journal Articles

Efficacy Analysis With Imatinib Monotherapy Was Superior To Allogeneic Hematopoietic Stem Transplantation In Pediatric Patients With Chronic Phase Of Chronic Myelogenous Leukemia

Hao Jiang, Daihong Liu, Lanping Xu, Kaiyan Liu, Shanshan Chen, MD, Bin Jiang, MD, Qian Jiang, Huan Chen, Yuhong Chen, Wei Han, MD, Xiaohui Zhang, Yazhen Qin, Yueyun Lai, Yanrong Liu, MD, PhD, Xiaojun Huang

Blood (2013) 122 (21): 4035.

https://doi.org/10.1182/blood.V122.21.4035.4035

Published: 2013

Journal Articles

CD58-Negtive Leukemia Initiating Cells Are Independently Associated with High Risk of Relapse in B-Precursor Acute Lymphoblastic Leukemia: A Comprehensive Clinical and Biological Profiling Study

Yuan Kong, MD, PhD, Yanrong Liu, MD, Honghu Zhu, PhD, Qian Jiang, MD, Hao Jiang, MD, Lan-Ping Xu, MD, Dai-Hong Liu, MD, PhD, Guo-Rui Ruan, PhD, Bin Jiang, MD, Kaiyan Liu, MD, Xiao-jun Huang, MD, PhD

Blood (2012) 120 (21): 1397.

https://doi.org/10.1182/blood.V120.21.1397.1397

Published: 2012

Journal Articles

Chronic Myelogenous Leukemia Patients with Highly Nilotinib-Resistant BCR-ABL Mutations Demonstrate Similar Efficacy to Dasatinib, but Have a Higher Likelihood of Developing New Mutations in the Event of Clinical Resistance

Qian Jiang, MD, Ya-Zhen Qin, MS, Yue-Yun Lai, MD, Bin Jiang, MD, Hao Jiang, Hong-Xia Shi, MD, Xiao-Jun Huang, MD

Blood (2012) 120 (21): 3755.

https://doi.org/10.1182/blood.V120.21.3755.3755

Published: 2012

Journal Articles

Arsenic Containing Triple-Agent Therapy for Acute Promyelocytic Leukemia-Comparison of Tetra-Arsenic Tetra-Sulfide vs. Arsenic Trioxide in the Long-Term Follow-up at a Single Hospital.

Shu-Lan Wu, MD, Dao-Pei Lu, MD, Yan-Li Zhao, MD, Lan-Qing Liang, MD, Jun-Bao He, MD, Wei Zou, MD, Xin-Hong Fei, MD, Bin Jiang, MD, Fu-Xiang Shan, MD, Ping-Di Yang, MD, Jie Zhao, MD, Chun-Rong Tong, MD

Blood (2010) 116 (21): 1081.

https://doi.org/10.1182/blood.V116.21.1081.1081

Published: 2010

Journal Articles

Imatinib Mesylate Versus Allogeneic HSCT for Patients with Chronic Myelogenous Leukemia In Accelerated Phase: A Single Center Experience In China After a 9-Year Follow-up

Qian Jiang, Lan-Ping Xu, Dai-Hong Liu, Kaiyan Liu, MD, PhD, Shan-Shan Chen, Bin Jiang, MD, Hao Jiang, Huan Chen, Yu-Hong Chen, Wei Han, Xiao-hui Zhang, Yu Wang, Ya-Zhen Qin, Yan-Rong Liu, Yue-yun Lai, Xiao Jun Huang

Blood (2010) 116 (21): 2347.

https://doi.org/10.1182/blood.V116.21.2347.2347

Published: 2010

Journal Articles

Bortezomib Plus Thalidomide Treatment of Newly Diagnosed Patients with Multiple Myeloma - Efficacy and Neurotoxicity: Results of a Multicenter Study.

Shilun Chen, MD, Bin Jiang, MD, Lugui Qiu, MD, Li Yu, MD, Yuping Zhong, MD, Wen Gao, MD

Blood (2007) 110 (11): 3600.

https://doi.org/10.1182/blood.V110.11.3600.3600

Published: 2007

Journal Articles

An Open-Label Study of Pegylated Liposomal Doxorubicin, Vincristine and Reduced-Dose Dexamethasone Combination Therapy in Newly Diagnosed Multiple Myeloma Patients in Chinese Population.

Yang Shen, MD, Zhixiang Shen, MD, Bin Jiang, MD, Jian Hou, MD, Rong Zhan, MD, Lugui Qiu, MD, Yongji Wu, MD, Jie Jin, MD, Juan Li, MD, Fanyi Meng, MD, Ping Zou, MD, Ting Liu, MD, Jianyong Li, MD, Chun Wang, MD, Depai Wu, MD, Jun Ma, MD

Blood (2007) 110 (11): 4816.

https://doi.org/10.1182/blood.V110.11.4816.4816

Published: 2007

NARROW

A Phase I/IIa Study of Lemzoparlimab, a Monoclonal Antibody Targeting CD47, in Patients with Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS): Initial Phase I Results

Retrospective Study Evaluating Hematological Remission Rates and Survival in Chinese Adults with Relapsed or Refractory (r/r) Philadelphia Chromosome Negative (Ph - ) B-Precursor Acute Lymphoblastic Leukemia (ALL)

Prevalence and Prognostic Significance of c-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia: A Comprehensive Large-Scale Study from a Single Chinese Center

KIT Mutation Versus MRD, Which Is More Important To Predict Relapse Of Acute Myeloid Leukemia With t (8; 21)?

Efficacy Analysis With Imatinib Monotherapy Was Superior To Allogeneic Hematopoietic Stem Transplantation In Pediatric Patients With Chronic Phase Of Chronic Myelogenous Leukemia

CD58-Negtive Leukemia Initiating Cells Are Independently Associated with High Risk of Relapse in B-Precursor Acute Lymphoblastic Leukemia: A Comprehensive Clinical and Biological Profiling Study

Chronic Myelogenous Leukemia Patients with Highly Nilotinib-Resistant BCR-ABL Mutations Demonstrate Similar Efficacy to Dasatinib, but Have a Higher Likelihood of Developing New Mutations in the Event of Clinical Resistance

Arsenic Containing Triple-Agent Therapy for Acute Promyelocytic Leukemia-Comparison of Tetra-Arsenic Tetra-Sulfide vs. Arsenic Trioxide in the Long-Term Follow-up at a Single Hospital.

Imatinib Mesylate Versus Allogeneic HSCT for Patients with Chronic Myelogenous Leukemia In Accelerated Phase: A Single Center Experience In China After a 9-Year Follow-up

Bortezomib Plus Thalidomide Treatment of Newly Diagnosed Patients with Multiple Myeloma - Efficacy and Neurotoxicity: Results of a Multicenter Study.

An Open-Label Study of Pegylated Liposomal Doxorubicin, Vincristine and Reduced-Dose Dexamethasone Combination Therapy in Newly Diagnosed Multiple Myeloma Patients in Chinese Population.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only